Biotechnology Value Fund L P - Sep 30, 2025 SCHEDULE 13G/A Report for PALVELLA THERAPEUTICS, INC. Common Stock, $0.001 par value per share (PVLA)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
PALVELLA THERAPEUTICS, INC. Common Stock, $0.001 par value per share
Symbol
PVLA
Shares outstanding
11.8M shares
Disclosed Ownership
1.18M shares
Ownership
9.99%
Form type
SCHEDULE 13G/A
Date filed
11/14/2025, 04:19 PM
Date of event
Sep 30, 2025
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 5.4% 634K 0 634K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 5.4% 634K 0 634K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 4% 475K 0 475K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 4% 475K 0 475K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.5% 54.8K 0 54.8K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.5% 54.8K 0 54.8K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 9.4% 1.11M 0 1.11M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 9.99% 1.18M 0 1.18M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 9.99% 1.18M 0 1.18M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 9.99% 1.18M 0 1.18M /s/ Mark N. Lampert Mark N. Lampert